Header Logo

Connection

Yehuda Handelsman to Receptors, Glucagon

Back to Details
This is a "connection" page, showing publications Yehuda Handelsman has written about Receptors, Glucagon.
Yehuda Handelsman
Connection Strength
0.455
Receptors, Glucagon
  1. Efficacy and safety of the once-weekly GLP-1 receptor agonist albiglutide versus sitagliptin in patients with type 2 diabetes and renal impairment: a randomized phase III study. Diabetes Care. 2014 Oct; 37(10):2723-30.
    View in: PubMed
    Score: 0.455
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.